Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2026-03-14 @ 9:23 PM
Study NCT ID:
NCT01784718
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2013-02-06
First Post:
2013-02-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Buphenyl Therapy for Byler's Disease
Sponsor:
University of Pittsburgh
Organization:
Study Overview
Official Title:
Compassionate Use of Buphenyl® in the Treatment of Byler's Disease
Status:
NO_LONGER_AVAILABLE
Status Verified Date:
2013-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single patient compassionate use protocol to determine whether Buphenyl (4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: